|
Contents
|
|
|
|
Oligoastrocytic
Tumors
|
|
|
|
|
Passarin
MG, Moretto G, Musso AM, Ottaviani S, Masotto B, Ghimenton C, Iuzzolino P,
Buffone E, Rudà R, Soffietti R, Vattemi E, Pedersini R
Intrathecal
liposomal cytarabine in combination with temozolomide in low-grade
oligoastrocytoma with leptomeningeal dissemination
J
Neurooncol. 2010 May;97(3):439-44. Epub 2009 Oct 31
.JPG)
Abstract |
.png)
Full Text | .png)
Reprint
|
|
|
Gliomas
|
|
|
|
The
Neuro-Oncology Working Group Of The German Cancer Society
Neuro-oncology
working group 01 trial of nimustine plus teniposide versus nimustine plus
cytarabine chemotherapy in addition to involved-field radiotherapy in the
first-line treatment of malignant glioma
J Clin Oncol. 2003 Sep 1;21(17):3276-84 (PDF Full Text)
|
|
|
Medulloblastoma
|
|
|
|
Celecoxib,
Cytarabine, Etoposide, Thalidomide
|
Nygaard
R, Kivivuori SM.
Treatment for recurrent
medulloblastoma with intrathecal liposomal cytarabine and systemic
metronomic combination therapy.
Anticancer Drugs. 2011 Dec 12;.
[Epub ahead of print]
Abstract |
.gif) Related articles
|
|
|
Pediatric
Patients
|
|
|
|
|
Lassaletta
A, Lopez-Ibor B, Mateos E, Gonzalez-Vicent M, Perez-Martinez A, Sevilla J,
Diaz MA, Madero L
Intrathecal
liposomal cytarabine in children under 4 years with malignant brain tumors
J Neurooncol.
2009 Apr 18. [Epub ahead of print]
Abstract
|
|
|
Primary
CNS Lymphoma
|
|
|
|
|
Garcia-Marco JA, Panizo C, Garcia ES, Deben G,
Alvarez-Larran A, Barca EG, Sancho JM, Penarrubia MJ, Garcia-Cerecedo T,
Vela JA
Efficacy
and safety of liposomal cytarabine in lymphoma patients with central nervous
system involvement from lymphoma
Cancer. 2009 May
1;115(9):1892-8
Abstract
|
|
|
Illerhaus G, Marks R, Ihorst G, Guttenberger R,
Ostertag
C, Derigs G, Frickhofen N, Feuerhake F, Volk B, Finke J.
High-dose chemotherapy with autologous
stem-cell transplantation and hyperfractionated radiotherapy as first-line
treatment of primary CNS lymphoma.
J
Clin Oncol. 2006 Aug
20;24(24):3865-70. Epub 2006 Jul 24.
Abstract
|
|
|
|
